Ghosh et al., 2006 - Google Patents
Toll-like receptor (TLR) 2–9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responsesGhosh et al., 2006
- Document ID
- 10058659494129318578
- Author
- Ghosh T
- Mickelson D
- Fink J
- Solberg J
- Inglefield J
- Hook D
- Gupta S
- Gibson S
- Alkan S
- Publication year
- Publication venue
- Cellular immunology
External Links
Snippet
The cells of innate and adaptive immunity, although activated by different ligands, engage in cross talk to ensure a successful immune outcome. To better understand this interaction, we examined the demographic picture of individual TLR (TLRs 2–9)-driven profiles of eleven …
- 239000000556 agonist 0 title abstract description 108
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ghosh et al. | Toll-like receptor (TLR) 2–9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses | |
Ghosh et al. | TLR–TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-α | |
Parker et al. | Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity | |
Isailovic et al. | Interleukin-17 and innate immunity in infections and chronic inflammation | |
Sepulcre et al. | The activation of gilthead seabream professional phagocytes by different PAMPs underlines the behavioural diversity of the main innate immune cells of bony fish | |
Jutel et al. | Immune regulation by histamine | |
Wesch et al. | Modulation of γδ T cell responses by TLR ligands | |
Trinchieri | Interleukin-12 and the regulation of innate resistance and adaptive immunity | |
Fitzgerald-Bocarsly et al. | The role of type I interferon production by dendritic cells in host defense | |
Zhang et al. | Type I interferons protect neonates from acute inflammation through interleukin 10–producing B cells | |
Park et al. | Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1 | |
Goldberg et al. | The unusual suspects—innate lymphoid cells as novel therapeutic targets in IBD | |
Bekeredjian-Ding et al. | Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN | |
Alfano et al. | Role of cytokines and chemokines in the regulation of innate immunity and HIV infection | |
Pashenkov et al. | Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections | |
Bekeredjian-Ding et al. | T cell-independent, TLR-induced IL-12p70 production in primary human monocytes | |
Brugnolo et al. | The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-γ–producing cells | |
Gupta | Role of dendritic cells in innate and adaptive immune response in human aging | |
Zhang et al. | Pathogenesis of infections in HIV-infected individuals: insights from primary immunodeficiencies | |
Manni et al. | β2-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response | |
Darcissac et al. | The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells | |
WO2015181298A1 (en) | Pharmaceutical combinations for immunotherapy | |
Maldonado et al. | Antifungal activity of plasmacytoid dendritic cells and the impact of chronic HIV infection | |
Nouri-Shirazi et al. | TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells | |
Abel et al. | Anatomic site and immune function correlate with relative cytokine mRNA expression levels in lymphoid tissues of normal rhesus macaques |